#2 - Johnson and Johnson (NSE:JNJ)
It’s almost too easy to talk about Johnson & Johnson’s (JNJ) status as a Dividend Aristocrat as a reason this stock should be in your portfolio during a recession, but it’s hard to overstate. J&J is one of only 19 companies that can say they have offered 50 consecutive years of dividend growth. That’s a long time. And it shows no sign of ending. This is because of a well-diversified portfolio both in terms of the products they provide and the markets in which those products are sold. They offer brands that are literally household names such as Neutrogena and Listerine.
The company has three operating segments that are proven to weather economic headwinds: pharmaceuticals, medical devices, and consumer health. Normally, having diversification over several segments allows one or two units to pick up the slack when others underperform. In the case of J&J, all their business units continue to make a profit, allowing the company to generate significant cash flow, which should allow them to continue to issue a healthy dividend, making this stock very attractive to investors.
About
- Current Price
- 0.00
- Consensus Rating
- N/A
- Ratings Breakdown
- 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- N/A
